The
Oncology Biosimilars Global Market Report 2024 by The Business Research Company
provides market overview across 60+ geographies in the seven regions -
Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the
Middle East, and Africa, encompassing 27 major global industries. The report
presents a comprehensive analysis over a ten-year historic period (2010-2021)
and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Oncology Biosimilars Market:
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report
According to The Business Research Company’s Oncology Biosimilars Global Market
Report 2024, The oncology biosimilars market size has grown exponentially in
recent years. It will grow from $6.9 billion in 2023 to $8.85 billion in 2024
at a compound annual growth rate (CAGR) of 28.3%. The
growth in the historic period can be attributed to rising prevalence of
cancer, patent expirations of biologic cancer drugs, government support for
biosimilars, growing investments in biosimilar development and manufacturing,
expanding geographical reach of biosimilars.
The oncology biosimilars market size is expected to see exponentially grown in
the next few years. It will grow to $16.48 billion in 2028 at a compound annual
growth rate (CAGR) of 16.8%. The growth
in the forecast period can be attributed to expanding oncology biosimilar
portfolio, patient-centric care, healthcare cost containment, targeted
therapies, expanding pipeline. Major trends in the forecast period include
biobetters, oncology biosimilar combinations, supportive care biosimilars,
real-world evidence.
The expiration of the patent of biologics used for the treatment of cancer is
driving the production of new oncology biosimilars. Biologics can be patented
for a limited period and the expiration of patents for biologics allows the
development of new biosimilars. Biologics are targeted drugs synthesized from
living organisms that induce the immune system to attack cancer cells.
Biosimilars are similar to biologics but are not identical and offer the same
effectiveness as biologics at a reduced cost. According to the Center for
Biosimilars, patents on nearly 20 oncology biologics will expire by 2023,
leading to the development of new biosimilars in cancer care. The increased
number of patent expiry is expected to boost the demand for the production of
new oncology biosimilars, thus, driving the market growth for oncology
biosimilars.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2821&type=smp
The oncology biosimilars market covered in this report is segmented –
1) By Drug Type: Monoclonal Antibody, Immunomodulators, Hematopoietic Agents,
Granulocyte Colony-Stimulating Factor (G-CSF)
2) By Cancer Type: Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia
Cancer, Non-Small Cell Lung Cancer, Other Cancer Types
3) By Distribution Type: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Major companies in the ophthalmic microscope market are focusing on developing
digital platforms, such as digital surgical visualization platforms, to gain a
competitive edge in the market. A digital surgical visualization platform is an
advanced technological system designed to provide enhanced visual capabilities
during surgical procedures. For instance, in April 2023, Bausch + Lomb, a
US-based eye health products company, jointly with Heidelberg Engineering, a
US-based high-tech imaging solutions company, launched SeeLuma, a fully digital
surgical visualization platform, presenting a cutting-edge solution for
ophthalmic surgeons. This advanced platform offers superior visualization
compared to existing microscopes, with features such as a heads-up 3D monitor,
multiple digital display options, and an intuitive interface. The platform
design includes digital binoculars for ergonomic posture and an interactive
Assist Mode for real-time support.
The oncology biosimilars market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment